Search | Clinical Trials Finder

Conditions: Unintended Pregnancy, Family Planning, Intimate Partner Violence (IPV)
Interventions: Jovenes Sanos; Behavioral
Lead sponsor: University of California, San Diego; Other
Eligibility: 16 Years to 20 Years · Female only
Enrollment: 124 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Intimate Partner Violence
Interventions: SHE Program; Behavioral
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2019
U.S. locations: 4
States / cities: Attleboro, Massachusetts • Akron, Ohio • Providence, Rhode Island + 1 more

Conditions: Diphtheria, Tetanus, Haemophilus Infection, Pertussis, Polio
Interventions: Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®; Biological
Lead sponsor: Sanofi; Industry
Eligibility: 42 Days to 89 Days
Enrollment: 1,167 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2006
U.S. locations: 23
States / cities: Montgomery, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 19 more

Conditions: Partner Abuse
Interventions: Onsite IPV specialist, Empowerment focused intervention; Behavioral
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 1,200 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 1
States / cities: Hartsville, South Carolina

Conditions: Violence, Domestic, HIV, Stigma, Social, Engagement, Patient, Medication Adherence
Interventions: 1MoreStep, 1MoreStepControl; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Intimate Partner Violence
Interventions: Usual Care Safety Planing App, Personalized App-Based Safety Decision Aid; Behavioral
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years to 24 Years
Enrollment: 649 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2020
U.S. locations: 4
States / cities: Phoenix, Arizona • Baltimore, Maryland • Columbia, Missouri + 1 more

Conditions: Polio Immunity
Interventions: IPOL (Sanofi Pasteur) inactivated polio vaccine booster dose; Drug
Lead sponsor: Eastern Virginia Medical School; Other
Eligibility: 18 Years to 90 Years
Enrollment: 231 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Norfolk, Virginia

Conditions: Diphtheria, Acellular Pertussis, Tetanus
Interventions: Prophylaxis: Diphtheria, tetanus, pertussis, poliovirus type 1, type 2 and type 3; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 4 Years to 6 Years
Enrollment: 401 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2002 – 2004
U.S. locations: 15
States / cities: Jonesboro, Arkansas • Fountain Valley, California • Oakland, California + 12 more

Conditions: SARS-CoV-2
Interventions: Vaccinated with polio vaccine (IPV); Biological
Lead sponsor: E-MO Biology Inc; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: National City, California

Conditions: Telemedicine
Interventions: MHP; Other
Lead sponsor: Naima Health LLC; Other
Eligibility: 18 Years and older · Female only
Enrollment: 150 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Rotavirus Infection, Rotavirus Vaccines
Interventions: Rotarix, Pediarix, Hiberix, Prevenar 13; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 6 Weeks to 12 Weeks
Enrollment: 1,280 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 47
States / cities: Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 40 more

Conditions: Interpersonal Violence
Interventions: Program for Alleviating Relationship Trauma and Stress through New Behaviors (PARTS-NB); Behavioral
Lead sponsor: Cambridge Health Alliance; Other
Eligibility: 18 Years and older · Male only
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 2
States / cities: Malden, Massachusetts • Tumwater, Washington

Conditions: Opioid Use Disorder, Intimate Partner Violence (IPV), Post Traumatic Stress Disorder PTSD
Interventions: PCT+2HOPE; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 532 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Bridgeport, Connecticut • Enfield, Connecticut • West Haven, Connecticut

Conditions: Domestic Violence, Post-Traumatic Stress Disorder, Depression
Interventions: Computer screen with community resource printout; Procedure
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 569 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2007
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Violence, Emotional Abuse, Pregnancy, Parenting
Interventions: Enhanced NFP (NFP+), NFP as usual; Behavioral
Lead sponsor: Portland State University; Other
Eligibility: 15 Years to 40 Years · Female only
Enrollment: 238 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Intimate Partner Violence
Interventions: ROSE Program; Behavioral
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 18 Years and older · Female only
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Meningococcal Disease
Interventions: MenACWY-CRM, DTaP-IPV/Hib, HBV, PCV, MMR; Biological
Lead sponsor: Novartis Vaccines; Industry
Eligibility: 55 Days to 89 Days
Enrollment: 529 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 42
States / cities: Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 33 more

Conditions: Domestic Violence
Interventions: Fatherhood Focused FVEP (F3), Family Violence Education Program (FVEP); Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Childhood Cancer, Multiple Diseases
Interventions: Immunization Schedule patients <7 years., Immunization Schedule patients > or = to 7 years and <11 years of age, Immunization Schedule patients > or = to 11 years of age; Biological
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 2 Years to 18 Years
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2025
U.S. locations: 1
States / cities: New York, New York

Conditions: HIV, Violence, Gender-Based, Pre-Exposure Prophylaxis
Interventions: Individual PrEP Decision Aid, CDC PrEP Video, Shared PrEP Decision Aid; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 18 Years and older · Female only
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Infections, Meningococcal
Interventions: Bexsero (GSK Biologicals' Meningococcal group-B vaccine/ rMenB+OMV NZ), Prevnar13, Pediarix, Hiberix, Rotarix, M-M-R II, Varivax, Placebo (saline water), Prevnar 20; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 6 Weeks to 12 Weeks
Enrollment: 1,196 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2024
U.S. locations: 56
States / cities: Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 47 more

Conditions: Gender-based Violence, Intimate Partner Violence
Interventions: Virtual Safe Dates for Young Parents, HealthSmart; Behavioral
Lead sponsor: RTI International; Other
Eligibility: 16 Years to 21 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Sexual Violence, Intimate Partner Violence (IPV)
Interventions: Enumerated anti-bullying state legislation, Conversion therapy state legislation, Gender-affirming care state legislation; Other
Lead sponsor: University of California, Berkeley; Other
Eligibility: 13 Years to 18 Years
Enrollment: 30 participants
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Berkeley, California

Conditions: HIV, Violence, Gender-Based, Violence, Domestic, Risk Reduction Behavior
Interventions: Program STARS (Supporting Trans Affirmation, relationships, and Sex), Relaxation and Stress Reduction; Behavioral
Lead sponsor: Brown University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Providence, Rhode Island

Search by objective public record fields.

Jovenes Sanos: Preventing IPV and RC

Intervention for Battered Sheltered Women With Substance Use Randomized Trial

Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™

Intimate Partner Violence (IPV)Screening in Health Care Clinics in Rural South Carolina

1MoreStep: An Intervention to Increase HIV Care Engagement and Reduce Intimate Partner Violence Among Black Women Living With HIV

Effectiveness of a Safety App to Respond to Dating Violence for College Women and Their Friends

Intradermal Versus Intramuscular Polio Vaccine Booster in HIV-Infected Subjects

Comparison of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP and IPV Separately Administered Vaccines in Terms of Immune Response and Safety

Polio Vaccine (IPV) for SARS-CoV-2 and Prevention of Coronavirus Disease (COVID-19)

Evaluation of MHP 3.0 in Two Clinical Settings

This Study Will Evaluate the Immunogenicity, Reactogenicity and Safety of the Routine Infant Vaccines Pediarix®, Hiberix® and Prevenar 13® When Co-administered With GlaxoSmithKline (GSK) Biologicals' Liquid Human Rotavirus Vaccine (HRV) as Compared to GSK's Licensed Lyophilized Vaccine

Program for Alleviating and Reducing Trauma and Stress for Intimate Partner Violence

Project STRONGER: Stepped Care for Opioid Use Disorder Treatment Engagement and Recovery

Mental Health Symptoms and Intimate Partner Violence

Enhanced Nurse Home Visitation to Prevent Intimate Partner Violence

Intervention for IPV Perinatal Women- RCT

A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months

Fatherhood Focused Family Violence Education Program

Prospective Trial of Vaccine Responses in Childhood Cancer Survivors

Development and Evaluation of a PrEP Decision Aid for Women Seeking Domestic Violence Services in Baltimore

Safety and Immunogenicity of GSK Meningococcal Group B Vaccine and 13-valent Pneumococcal Vaccine Administered Concomitantly With Routine Infant Vaccines to Healthy Infants

Virtual Village for Young Parents

Evaluation of State-Level Sexual and Gender Minority Laws for the Primary Prevention of Sexual and Intimate Partner Violence Among Sexual and Gender Minority Youth in the U.S.

Supporting Trans Affirmation, Relationships, and Sex, Phase 3